Skip to content

Acupuncture for patients with ischemic stroke in the acute stage: a randomized controlled trial

Acupuncture for patients with ischemic stroke in the ovall stages: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068757
Enrollment
Unknown
Registered
2023-02-28
Start date
2023-03-01
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Interventions

Sham acupuncture group:Sham acupuncture with basic drug treatment and rehabilitation program

Sponsors

The Affiliated TCM Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with acute ischemic stroke within 7 days after stroke onset by relevant clinical symptoms and CT/CTA/MRI or DSA. 2. Patients aged between 18 to 80. 3. Patients with stable vital signs and normal MMSE scores and have ability to cooperate with the acupuncture treatment and basic rehabilitation training.

Exclusion criteria

Exclusion criteria: 1. Transient ischemic attack, reversible neurological deficit; After examination, it has been confirmed that neurological deficits are caused by diseases such as brain tumors, traumatic brain injury, cerebral hemorrhage, and cerebral parasites. Patients with life expectancy other than stroke are less than 1 year; 2. Pregnant or lactating women, as well as women with fertility intentions within the past 3 months; 3. Patients with acupuncture and moxibustion Contraindication, complicated with serious primary diseases such as heart, liver, kidney, hematopoietic system, Endocrine system and infectious or infectious diseases; Patients with bleeding tendencies or hemorrhagic diseases; Individuals with a history of needle sickness and blood sickness; Patients with severe Aphasia, sleep apnea, deafness, severe cognitive impairment and inability to communicate normally; Or those who are participating in other clinical research trials; 4. Patients who refuse to sign informed consent forms.

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale(mRS);

Secondary

MeasureTime frame
Changes in the microcirculatory blood flow near acupoints;NIH Stroke Scale(NIHSS));the Barthel index;Fugl-Meyer Assessment(FMA));

Countries

China

Contacts

Public ContactChuyun Chen

The Affiliated TCM Hospital of Guangzhou Medical University

chencyzwl@126.com+86 139 2402 6576

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026